hydroxyindoleacetic acid has been researched along with Syndrome in 42 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the purported role of central monoamine disturbances in the pathophysiology of the opsoclonus-myoclonus syndrome, the serotonin metabolite 5-hydroxyindoleacetic acid and the dopamine metabolite homovanillic acid were measured in cerebrospinal fluid samples from 27 affected children and 47 age- and gender-matched control subjects by high-pressure liquid chromatography with electrochemical detection." | 9.08 | Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome. ( Banasiak, K; Gospe, SM; Huang, Y; Noetzel, MJ; Pranzatelli, MR; Stanley, M; Tate, E, 1995) |
| "Combination treatment with fluoxetine and moclobemide did not provide any indication of development of the "serotonin syndrome." | 9.08 | Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the "serotonin syndrome". ( Amrein, R; Dingemanse, J; Gieschke, R; Guentert, T; Wallnöfer, A, 1998) |
| "The aim of the present study was to investigate the discriminative power of a series of variables (including determination of depressive symptomatology by means of a visual analogue scale, determination of personality traits by means of the Karolinska Scales of Personality, determination of monoamine metabolites in CSF, platelet MAO activities, serum cortisol before and after dexamethasone suppression and urinary melatonin) in differentiating chronic pain patients from healthy subjects, and patients with idiopathic pain syndromes from patients with neurogenic pain syndromes." | 7.67 | Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating, personality traits, monoamine metabolites in CSF, serum cortisol, platelet MAO and urinary melatonin. ( Almay, BG; Häggendal, J; Johansson, F; Oreland, L; von Knorring, L; Wetterberg, L, 1986) |
| "Exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces a syndrome that resembles Parkinson's disease." | 7.67 | The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). ( Burns, RS; Ebert, MH; Kopin, IJ; LeWitt, PA; Pakkenberg, H, 1985) |
| "Treatment with 5-hydroxytryptophan (4-6 mg/kg) and carbidopa (0." | 6.70 | A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa. ( Abeling, N; Bergmann, C; Blau, N; Häring, M; Häusler, M; Heimann, G; Ramaekers, VT; Senderek, J; Zerres, K, 2001) |
| "To study the purported role of central monoamine disturbances in the pathophysiology of the opsoclonus-myoclonus syndrome, the serotonin metabolite 5-hydroxyindoleacetic acid and the dopamine metabolite homovanillic acid were measured in cerebrospinal fluid samples from 27 affected children and 47 age- and gender-matched control subjects by high-pressure liquid chromatography with electrochemical detection." | 5.08 | Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome. ( Banasiak, K; Gospe, SM; Huang, Y; Noetzel, MJ; Pranzatelli, MR; Stanley, M; Tate, E, 1995) |
| "Combination treatment with fluoxetine and moclobemide did not provide any indication of development of the "serotonin syndrome." | 5.08 | Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the "serotonin syndrome". ( Amrein, R; Dingemanse, J; Gieschke, R; Guentert, T; Wallnöfer, A, 1998) |
| " The interaction between tianeptine and drugs known to interfere with the uptake or release of serotonin (sertraline, buspirone, D-norfenfluramine) was then studied and, to ascertain the in vivo pharmacological relevance of tianeptine's effects, its ability to reduce the serotoninergic syndrome was evaluated." | 3.68 | In vivo studies on the enhancement of serotonin reuptake by tianeptine. ( Clavenna, A; De Luigi, A; De Simoni, MG; Manfridi, A, 1992) |
| "The aim of the present study was to investigate the discriminative power of a series of variables (including determination of depressive symptomatology by means of a visual analogue scale, determination of personality traits by means of the Karolinska Scales of Personality, determination of monoamine metabolites in CSF, platelet MAO activities, serum cortisol before and after dexamethasone suppression and urinary melatonin) in differentiating chronic pain patients from healthy subjects, and patients with idiopathic pain syndromes from patients with neurogenic pain syndromes." | 3.67 | Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating, personality traits, monoamine metabolites in CSF, serum cortisol, platelet MAO and urinary melatonin. ( Almay, BG; Häggendal, J; Johansson, F; Oreland, L; von Knorring, L; Wetterberg, L, 1986) |
| "Exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces a syndrome that resembles Parkinson's disease." | 3.67 | The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). ( Burns, RS; Ebert, MH; Kopin, IJ; LeWitt, PA; Pakkenberg, H, 1985) |
| "26 patients with a paranoid-hallucinatory syndrome were treated with a fixed daily dose of haloperidol." | 3.65 | Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol. ( Ackenheil, M; Eben, E; Hippius, H; Rüther, E; Schilkrut, R, 1976) |
| "Treatment with 5-hydroxytryptophan (4-6 mg/kg) and carbidopa (0." | 2.70 | A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa. ( Abeling, N; Bergmann, C; Blau, N; Häring, M; Häusler, M; Heimann, G; Ramaekers, VT; Senderek, J; Zerres, K, 2001) |
| "Patients with carcinoid tumours require a multidisciplinary approach to their care." | 2.41 | Carcinoid syndrome symposium on treatment modalities for gastrointestinal carcinoid tumours: symposium summary. ( DiFrancesco, LM; Kinnear, S; McEwan, A; McKinnon, JG; Numerow, L; Pasieka, JL; Paterson, A; Rorstad, O; Skogseid, B; Yelle, CA, 2001) |
| "This syndrome is an anxiety state occurring in the presence of elevated levels of atmospheric or ambient cations and is associated with elevated central and peripheral serotonin levels." | 2.37 | The serotonin irritation syndrome--a new clinical entity? ( Giannini, AJ; Malone, DA; Piotrowski, TA, 1986) |
| " Dose-response curves created with 8-OH DPAT for the serotonin behavioral syndrome were similar in bile duct-resected and sham-operated rats." | 1.33 | Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat. ( Bozdayi, AM; Bozkaya, H; Celik, T; Cinar, K; Gören, MZ; Gürdal, H; Onder, FO; Tan, A; Terzioğlu, B; Uzunalimoğlu, O; Yurdaydin, C, 2005) |
| "This syndrome is usually caused by endogenous dopamine deficiency but in these patients was associated with elevated dopamine metabolites in CSF and an unusual eye movement disorder: ocular flutter together with saccade initiation failure." | 1.32 | Infantile Parkinsonism-dystonia and elevated dopamine metabolites in CSF. ( Assmann, BE; Bräutigam, C; Heales, SJ; Hoffmann, GF; Hyland, K; Robinson, RO; Sharma, R; Surtees, RA; Wevers, RA; Zschocke, J, 2004) |
| "The Rett syndrome is a progressive disorder in female patients that is characterized by autistic behavior, dementia, ataxia, loss of purposeful use of the hands, and seizures." | 1.27 | Reduction of biogenic amine levels in the Rett syndrome. ( Butler, IJ; Glaze, DG; Percy, AK; Riccardi, VM; Zoghbi, HY, 1985) |
| "When reserpine was discontinued, symptoms recurred." | 1.26 | Sydenham's chorea: a possible presynaptic dopaminergic dysfunction initially. ( Naidu, S; Narasimhachari, N, 1980) |
| "In two patients with postanoxic action myoclonus, L-tryptophan or a monoamine oxidase inhibitor induced a moderate improvement, but L-5-hydroxytryptophan had greater therapeutic effect." | 1.26 | Beneficial effects of serotonin precursors in postanoxic action myoclonus. ( De Léan, J; Hornykiewicz, O; Richardson, JC, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (66.67) | 18.7374 |
| 1990's | 9 (21.43) | 18.2507 |
| 2000's | 5 (11.90) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assmann, BE | 1 |
| Robinson, RO | 1 |
| Surtees, RA | 1 |
| Bräutigam, C | 1 |
| Heales, SJ | 1 |
| Wevers, RA | 1 |
| Zschocke, J | 1 |
| Hyland, K | 1 |
| Sharma, R | 1 |
| Hoffmann, GF | 1 |
| Celik, T | 1 |
| Gören, MZ | 1 |
| Cinar, K | 1 |
| Gürdal, H | 1 |
| Onder, FO | 1 |
| Tan, A | 1 |
| Terzioğlu, B | 1 |
| Bozdayi, AM | 1 |
| Bozkaya, H | 1 |
| Uzunalimoğlu, O | 1 |
| Yurdaydin, C | 1 |
| Squires, LN | 1 |
| Talbot, KN | 1 |
| Rubakhin, SS | 1 |
| Sweedler, JV | 1 |
| Naidu, S | 1 |
| Narasimhachari, N | 1 |
| Yamamoto, M | 1 |
| Otsuki, S | 1 |
| Miyake, K | 1 |
| Namba, R | 1 |
| Cramer, H | 1 |
| Warter, JM | 1 |
| Renaud, B | 1 |
| Willemse, J | 1 |
| van Nieuwenhuizen, O | 1 |
| Gooskens, RH | 1 |
| Westenberg, HG | 1 |
| Koerber, RK | 1 |
| Torkelson, R | 1 |
| Haven, G | 1 |
| Donaldson, J | 1 |
| Cohen, SM | 1 |
| Case, M | 1 |
| van Kempen, GM | 1 |
| Farmer, KL | 1 |
| Pranzatelli, MR | 1 |
| Huang, Y | 1 |
| Tate, E | 1 |
| Stanley, M | 1 |
| Noetzel, MJ | 1 |
| Gospe, SM | 1 |
| Banasiak, K | 1 |
| Lima, L | 1 |
| Urbina, M | 1 |
| Drujan, B | 1 |
| Dingemanse, J | 1 |
| Wallnöfer, A | 1 |
| Gieschke, R | 1 |
| Guentert, T | 1 |
| Amrein, R | 1 |
| Pasieka, JL | 1 |
| McKinnon, JG | 1 |
| Kinnear, S | 1 |
| Yelle, CA | 1 |
| Numerow, L | 1 |
| Paterson, A | 1 |
| Rorstad, O | 1 |
| DiFrancesco, LM | 1 |
| McEwan, A | 1 |
| Skogseid, B | 1 |
| Ramaekers, VT | 1 |
| Senderek, J | 1 |
| Häusler, M | 1 |
| Häring, M | 1 |
| Abeling, N | 1 |
| Zerres, K | 1 |
| Bergmann, C | 1 |
| Heimann, G | 1 |
| Blau, N | 1 |
| Guilleminault, C | 2 |
| Phillips, R | 1 |
| Dement, WC | 2 |
| Billiard, M | 1 |
| Livrea, P | 1 |
| Puca, FM | 1 |
| Barnaba, A | 1 |
| Di Reda, L | 1 |
| Sulman, FG | 1 |
| Levy, D | 1 |
| Lunkan, L | 1 |
| Pfeifer, Y | 1 |
| Tal, E | 1 |
| Lupandin, VM | 1 |
| Lando, LI | 1 |
| Gromova, EA | 1 |
| Kamenskaia, VM | 1 |
| Zykov, MB | 1 |
| Diukova, GM | 1 |
| Bol'shakova, TD | 1 |
| Rodshtat, IV | 1 |
| Dibobes, GK | 1 |
| Tiabenkova, VF | 1 |
| Koskiniemi, M | 1 |
| Allen, N | 1 |
| Knopp, W | 1 |
| Michel, D | 1 |
| Tommasi, M | 1 |
| Laurent, B | 1 |
| Trillet, M | 1 |
| Schott, B | 1 |
| Rüther, E | 2 |
| Schilkrut, R | 2 |
| Ackenheil, M | 2 |
| Eben, E | 2 |
| Hippius, H | 2 |
| De Léan, J | 1 |
| Richardson, JC | 1 |
| Hornykiewicz, O | 1 |
| Russell, IJ | 1 |
| Vaeroy, H | 1 |
| Javors, M | 1 |
| Nyberg, F | 1 |
| De Simoni, MG | 1 |
| De Luigi, A | 1 |
| Clavenna, A | 1 |
| Manfridi, A | 1 |
| Linnoila, VM | 1 |
| Virkkunen, M | 1 |
| Nagata, R | 1 |
| Izumi, K | 1 |
| Iwata, S | 1 |
| Shimizu, T | 1 |
| Fukuda, T | 1 |
| Zoghbi, HY | 1 |
| Percy, AK | 2 |
| Glaze, DG | 1 |
| Butler, IJ | 1 |
| Riccardi, VM | 2 |
| Zoghbi, H | 1 |
| Giannini, AJ | 1 |
| Malone, DA | 1 |
| Piotrowski, TA | 1 |
| von Knorring, L | 2 |
| Oreland, L | 2 |
| Häggendal, J | 2 |
| Magnusson, T | 1 |
| Almay, B | 1 |
| Johansson, F | 2 |
| Almay, BG | 1 |
| Wetterberg, L | 1 |
| Burns, RS | 1 |
| LeWitt, PA | 1 |
| Ebert, MH | 1 |
| Pakkenberg, H | 1 |
| Kopin, IJ | 1 |
| Garelis, E | 1 |
| Sourkes, TL | 1 |
| Curzon, G | 1 |
| Ricci, C | 1 |
| Patrassi, N | 1 |
| Massa, R | 1 |
| Mineo, C | 1 |
| Benedetti-Valentini F, J | 1 |
| Riederer, P | 1 |
| Birkmayer, W | 1 |
| Neumayer, E | 1 |
| Ambrozi, L | 1 |
| Linauer, W | 1 |
| Bowers, MB | 1 |
5 reviews available for hydroxyindoleacetic acid and Syndrome
| Article | Year |
|---|---|
[Serotonin in neurology and psychiatry].
Topics: Brain; Brain Chemistry; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Monoamine Oxidase; Recep | 1995 |
Additional tests of interest to the dermatologist.
Topics: alpha 1-Antitrypsin Deficiency; Angioedema; Complement C1 Inactivator Proteins; Erythema; Glucagon; | 1994 |
Carcinoid syndrome symposium on treatment modalities for gastrointestinal carcinoid tumours: symposium summary.
Topics: Algorithms; Appendiceal Neoplasms; Carcinoid Tumor; Gastrointestinal Neoplasms; Humans; Hydroxyindol | 2001 |
Aggression, suicidality, and serotonin.
Topics: Age Factors; Aggression; Alcoholism; Circadian Rhythm; Depressive Disorder; Humans; Hydroxyindoleace | 1992 |
The serotonin irritation syndrome--a new clinical entity?
Topics: Animals; Anions; Anxiety; Atmosphere; Cations; Electricity; Guinea Pigs; Humans; Hydroxyindoleacetic | 1986 |
3 trials available for hydroxyindoleacetic acid and Syndrome
| Article | Year |
|---|---|
Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
Topics: Adrenal Cortex Hormones; Child; Child, Preschool; Chromatography, High Pressure Liquid; Electrochemi | 1995 |
Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the "serotonin syndrome".
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antidepressive Agents; Benzamides; Blood Platelets; Drug Admi | 1998 |
A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa.
Topics: 5-Hydroxytryptophan; Abnormalities, Multiple; Carbidopa; Child; Child, Preschool; Developmental Disa | 2001 |
34 other studies available for hydroxyindoleacetic acid and Syndrome
| Article | Year |
|---|---|
Infantile Parkinsonism-dystonia and elevated dopamine metabolites in CSF.
Topics: Dopamine; Dystonic Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant, N | 2004 |
Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Brain; Cholestasis; Dose-Response | 2005 |
Serotonin catabolism in the central and enteric nervous systems of rats upon induction of serotonin syndrome.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Brain; Central Nervous System; Disease Models, Anima | 2007 |
Sydenham's chorea: a possible presynaptic dopaminergic dysfunction initially.
Topics: Child; Chorea; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Aci | 1980 |
[Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
Topics: Acanthocytes; Adult; Aged; Atrophy; Brain Diseases; Chorea; gamma-Aminobutyric Acid; Homovanillic Ac | 1983 |
Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
Topics: Adult; Basal Ganglia Diseases; Cyclic AMP; Female; Homovanillic Acid; Humans; Huntington Disease; Hy | 1984 |
Treatment of non-fluctuating progressive dystonia: a neuropharmacological approach.
Topics: Adolescent; Basal Ganglia; Child; Chromatography, High Pressure Liquid; Dystonia; Female; Homovanill | 1984 |
Increased cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in Kleine-Levin syndrome.
Topics: Adolescent; Disorders of Excessive Somnolence; Feeding and Eating Disorders; Humans; Hydroxyindoleac | 1984 |
Increase of the serotonin metabolite, 5-hydroxyindoleacetic acid, in cerebro-spinal fluid and spinal cord of bovines affected with the paraplegic syndrome.
Topics: Animals; Cattle; Cattle Diseases; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Methoxyhydrox | 1995 |
A syndrome of hypersomnia with automatic behavior.
Topics: Adult; Attention; Automatism; Circadian Rhythm; Electroencephalography; Homovanillic Acid; Humans; H | 1975 |
A menstruation-linked periodic hypersomnia. Kleine-Levin syndrome or new clinical entity?
Topics: Adolescent; Disorders of Excessive Somnolence; Electroencephalography; Estrogens, Conjugated (USP); | 1975 |
Abnormal central monoamine metabolism in humans with "true hypersomnia" and "sub-wakefulness".
Topics: 3-Methoxy-4-hydroxyphenylethanol; Adolescent; Catechols; Child; Disorders of Excessive Somnolence; D | 1977 |
Absence of harmful effects of protracted negative air ionisation.
Topics: Air Ionization; Female; Histamine; Humans; Hydroxyindoleacetic Acid; Male; Serotonin; Syndrome; Thyr | 1978 |
[Role of biogenic amines in the pathogenesis of intellectual disorders in children with minimal psychoorganic syndromes].
Topics: Attention Deficit Disorder with Hyperactivity; Catecholamines; Child; Dihydroxyphenylalanine; Electr | 1978 |
[Clinico-neurohumoral interrelationships in neuroses].
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex; Adult; Catecholamines; Chromaffin System; Female; Humans; | 1978 |
Findings in routine laboratory examination in progressive myoclonus epilepsy.
Topics: Adolescent; Adult; Age Factors; Blood Glucose; Blood Proteins; Cerebrospinal Fluid Proteins; Child; | 1975 |
Hereditary Parkinsonism-dystonia with sustained control by L-DOPA and anticholinergic medication.
Topics: Adolescent; Adult; Aged; Dopamine beta-Hydroxylase; Dystonia Musculorum Deformans; Female; Growth Ho | 1976 |
[Striato-nigral degeneration. A propos of 2 anatomo-clinical cases].
Topics: Brain Diseases; Corpus Striatum; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; | 1976 |
Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol.
Topics: Adult; Female; Hallucinations; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mal | 1976 |
Clinical and biochemical parameters during neuroleptic treatment. II. Antipsychotic effect of haloperidol in patients with chronic organic brain damage.
Topics: Adult; Aged; Brain Damage, Chronic; Depression; Female; Hallucinations; Haloperidol; Homovanillic Ac | 1976 |
Beneficial effects of serotonin precursors in postanoxic action myoclonus.
Topics: 5-Hydroxytryptophan; Aged; Carbidopa; Female; Humans; Hydroxyindoleacetic Acid; Hypoxia; Levodopa; M | 1976 |
Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Biogenic Amines; Female; Fibromyalgia; Humans; Hydroxyindoleacet | 1992 |
In vivo studies on the enhancement of serotonin reuptake by tianeptine.
Topics: 1-Naphthylamine; Animals; Antidepressive Agents, Tricyclic; Buspirone; Drug Interactions; Hydroxyind | 1992 |
Mechanisms of veratramine-induced 5-HT syndrome in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Aci | 1991 |
Reduction of biogenic amine levels in the Rett syndrome.
Topics: Adolescent; Ataxia; Autistic Disorder; Biogenic Amines; Child; Child, Preschool; Dementia; Electroen | 1985 |
Rett syndrome: initial experience with an emerging clinical entity.
Topics: Adolescent; Biopsy; Child; Child Development; Child, Preschool; Electroencephalography; Female; Homo | 1985 |
Relationship between platelet MAO activity and concentrations of 5-HIAA and HVA in cerebrospinal fluid in chronic pain patients.
Topics: Age Factors; Blood Platelets; Body Height; Chronic Disease; Female; Homovanillic Acid; Humans; Hydro | 1986 |
Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating, personality traits, monoamine metabolites in CSF, serum cortisol, platelet MAO and urinary melatonin.
Topics: Adult; Chronic Disease; Depressive Disorder; Female; Homovanillic Acid; Humans; Hydrocortisone; Hydr | 1986 |
The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Corpus Striatum; Dopamine; Female; Homovanillic | 1985 |
Use of cerebrospinal fluid drawn at pneumoencephalography in the study of monoamine metabolism in man.
Topics: Adolescent; Adult; Brain Diseases; Epilepsy, Temporal Lobe; Epilepsy, Tonic-Clonic; Female; Homovani | 1974 |
Involuntary movements other than Parkinsonism: biochemical aspects.
Topics: Acute Disease; Animals; Athetosis; Basal Ganglia; Brain; Dopamine; Fecal Incontinence; Homovanillic | 1973 |
Carcinoid syndrome in bronchial adenoma.
Topics: Adenoma; Adult; Aged; Bronchial Neoplasms; Carcinoid Tumor; Female; Humans; Hydroxycorticosteroids; | 1973 |
The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depression-syndrome.
Topics: Benzoates; Chromatography, Thin Layer; Circadian Rhythm; Depression; Homovanillic Acid; Humans; Hydr | 1974 |
Central dopamine turnover in schizophrenic syndromes.
Topics: Affective Symptoms; Chlorpromazine; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic | 1974 |